IDEXX Laboratories Stock Target Price and Analyst Consensus
| IDXX Stock | USD 477.79 0.45 0.09% |
The current analyst and expert consensus on IDEXX Laboratories is Buy with 6 buy recommendations. The current projected IDEXX Laboratories target price consensus is 569.13, with 14 analyst opinions. The most common way IDEXX Laboratories analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to IDEXX Laboratories executives, vendors, and/or customers. IDEXX Laboratories buy-or-sell recommendation module provides average expert sentiment on the projected IDEXX Laboratories target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on IDEXX Laboratories to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
Lowest Forecast 517.91 | Highest Forecast 631.73 | Target Price 569.13 |
IDEXX |
It's important to approach IDEXX Laboratories' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
IDEXX Laboratories Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. IDEXX target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. IDEXX Laboratories' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Buy |
Most IDEXX analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand IDEXX stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of IDEXX Laboratories, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationIDEXX Laboratories Target Price Projection
IDEXX Laboratories' current and average target prices are 477.79 and 569.13, respectively. The current price of IDEXX Laboratories is the price at which IDEXX Laboratories is currently trading. On the other hand, IDEXX Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
IDEXX Laboratories Market Quote on 18th of April 2024
Target Price
Analyst Consensus On IDEXX Laboratories Target Price
IDEXX Laboratories Analyst Ratings
IDEXX Laboratories' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about IDEXX Laboratories stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of IDEXX Laboratories' financials, market performance, and future outlook by experienced professionals. IDEXX Laboratories' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize IDEXX Laboratories price targets
IDEXX Laboratories' stock target price is an estimate of its future price, usually made by analysts. Using IDEXX Laboratories' target price to determine if it is a suitable investment can be done through the following steps:- Look at IDEXX Laboratories' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if IDEXX Laboratories' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional IDEXX Laboratories Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of IDEXX Laboratories is a key component of IDEXX Laboratories valuation and have some predictive power on the future returns of a IDEXX Laboratories.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of IDEXX Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested over 70 shares | |
 | Manufacturing Invested over 40 shares | |
 | Driverless Cars Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Social Domain Invested few shares | |
 | Power Assets Invested over 200 shares | |
Check out Macroaxis Advice on IDEXX Laboratories to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
The data published in IDEXX Laboratories' official financial statements usually reflect IDEXX Laboratories' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of IDEXX Laboratories. For example, before you start analyzing numbers published by IDEXX accountants, it's critical to develop an understanding of what IDEXX Laboratories' liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of IDEXX Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IDEXX Laboratories' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in IDEXX Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of IDEXX Laboratories. Please utilize our Beneish M Score to check the likelihood of IDEXX Laboratories' management manipulating its earnings.